The drugmaker's shares rallied Monday following Friday's settlement with the Justice Department, resolving claims by Medicaid that Mylan overcharged the government health program for the allergy shot. That helped erase some of the …
Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports. Mylan's stock plunged after the maker of Epi …
* Mylan NV - ‍announced it is voluntarily delisting company’s ordinary shares from trading on tel aviv stock exchange * Mylan NV - ‍ delisting of Mylan’s ordinary shares from tase will become effective in three months, on February 12, 2018 ...
StockMarketWire.com - Indivior has confirmed that its US subsidiary, Indivior Inc, together with Monosol Rx, had entered into a settlement agreement with Mylan Pharmaceuticals, Mylan Technologies and Mylan NV resolving patent …
(Reuters) - Mylan NV rejected Teva Pharmaceutical Industries Ltd's $40 billion takeover offer on Monday, saying in a scathing letter that it grossly undervalued the company and that Mylan has no interest in payment in what it termed …
This week, companies like Allergan AGN, Teva TEVA and Mylan MYL were in the limelight. While Mylan and Teva …
NEW YORK–US stocks mostly fell Tuesday, but the Nasdaq stayed in positive territory as Israel’s Teva announced a $40.1 billion cash-and-stock bid for generic drug maker Mylan. The Dow Jones Industrial Average closed down 85.34 …
Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports.